William Blair & Company
EW icon

William Blair & Company’s Edwards Lifesciences EW Stock Holding History

William Blair & Company’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,400
Closed -$75K – 1638
2017
Q1 		$75K Hold
2,400
– – ﹤0.01% 1309
2016
Q4 		$75K Buy
+2,400
New +$77.8K ﹤0.01% 1236

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

William Blair & Company's EW Position: Q2 2026 in Review

William Blair & Company increased its Edwards Lifesciences (EW) stake by 13% in Q2 2026, buying an estimated $3.38M and bringing the position to 356,032 shares worth $32.2M. The position accounts for 0.08% of the portfolio, ranked #194.

William Blair & Company first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $122M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • William Blair & Company held 356,032 shares of Edwards Lifesciences worth $32.2M as of Q2 2026.
  • William Blair & Company bought 40,342 Edwards Lifesciences shares in Q2 2026, an estimated $3.38M.
  • Edwards Lifesciences made up 0.08% of William Blair & Company's portfolio in Q2 2026, its #194 holding.
  • William Blair & Company first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • William Blair & Company's Edwards Lifesciences position peaked at $122M in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.